Tag: Healthcare Research Award

Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Humanitas Castelli, Italy

Dr. Gabriele Cortina is an accomplished Orthopaedic and Traumatology Specialist recognized for his excellence in sports medicine, knee surgery, and joint reconstruction. He obtained his secondary diploma with distinction from Istituto Magistrale Luigi Pietrobono in Alatri (2006–2011) and earned his Laurea Magistrale a Ciclo Unico in Medicina e Chirurgia with 110/110 e lode from the Università Campus Bio-Medico di Roma in 2017, followed by professional qualification as a Medico-Chirurgo from Università degli Studi di Roma Tor Vergata (2018) and a specialization in Orthopaedics and Traumatology with 50/50 e lode from Campus Bio-Medico di Roma in 2023. Professionally, he serves as an orthopaedic surgeon at Cliniche Humanitas Gavazzeni-Castelli in Bergamo, Clinica Pierangeli in Pescara, and Clinica Santa Teresa in Isola del Liri, while also completing a prestigious Sport Medicine and Knee Surgery Fellowship at ICATME, Barcelona, under Prof. J.C. Monllau. His previous roles include specialization training at Humanitas Gavazzeni and Castelli Clinics and observerships in shoulder and hip surgery at Clinica Villa Verde (Fermo) and Villa Ulivella (Firenze). Dr. Cortina’s research interests focus on orthopaedic biomechanics, joint preservation, rehabilitation protocols, and regenerative therapies. His notable publications include studies on rotator cuff repair, osteoarthritis, kinematic knee alignment, and adipose tissue injection therapy in reputed journals such as The Knee, Osteology, Journal of Surgical Case Reports, and Journal of Experimental Orthopaedics. He is fluent in Italian and proficient in English and has actively participated in international conferences and cadaveric training courses across Europe, including SIAGASCOT, CADLAB Cologne, and M.O.R.E. Knee Learning Center. His research skills encompass clinical data analysis, surgical innovation, and multidisciplinary collaboration. Honors include multiple cum laude academic distinctions and recognition as a finalist in the LiGca-Lab Program by SIAGASCOT. In conclusion, Dr. Cortina embodies the fusion of clinical precision and academic depth, contributing to the advancement of modern orthopaedics through evidence-based practice, cross-border collaboration, and a lifelong commitment to improving musculoskeletal health.

Profiles: Scopus|ORCID

Featured Publications

  1. Cortina, G., Antuofermo, S. M., Papalia, G. F., Cortina, R., Condello, V., Perelli, S., Monllau, J. C., & Madonna, V. (2025). Limited clinical benefit of medial meniscus posterior root repair combined with high tibial osteotomy in varus knee osteoarthritis: A systematic review and meta‐analysis. Journal of Experimental Orthopaedics.
  2. Cortina, G., Collarile, M., Condello, V., Orlandi, R., Russo, A., Madonna, V., & Pieracci, N. (2021). Spinal hematoma after total knee arthroplasty: A case report. Journal of Surgical Case Reports.
  3. Berton, A., De Salvatore, S., Candela, V., Cortina, G., Lo Presti, D., Massaroni, C., Petrillo, S., & Denaro, V. (2020). Delayed rehabilitation protocol after rotator cuff repair. Osteology, 1(1), 3.
  4. Cortina, G. (2020). Physical activity for the treatment of chronic low back pain in elderly patients: A systematic review. Journal of Clinical Medicine, 9(4), 1023.
  5. Cortina, G. (2019). New trends in treatment of osteoarthritis: “From cells to metal”. A case report of simultaneous different approach to bilateral hip osteoarthritis. Annals of Case Report.

Dr. Gabriele Cortina’s work advances the field of orthopaedic science through innovative approaches in joint reconstruction, sports medicine, and regenerative therapy, bridging clinical excellence with translational research. His contributions enhance surgical outcomes, improve patient mobility, and foster global innovation in minimally invasive and evidence-based orthopaedic care.

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

AOU San Luigi Gonzaga Orbassano (Torino), Italy

Dr. Giovanni Musso is a renowned clinician and researcher in Internal Medicine with a distinguished academic and professional career. He graduated in Medicine in 1996 with top honors (110/110) and completed his specialization in Internal Medicine in 2002 with distinction. Currently serving at the Department of Internal Medicine, Humanitas Gradenigo Hospital, Turin, he has devoted his career to the study of lipid and glucose metabolism, with particular emphasis on non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), and related metabolic complications. He leads international collaborative research involving 34 centers worldwide, producing high-impact findings on NAFLD epidemiology, pathogenesis, and staging, with publications in PLOS Medicine, Hepatology, Gastroenterology, BMJ, and other leading journals. His research interests include lipidomics, postprandial metabolism, gut microbiota, metabolic inflammation, and therapeutic innovations such as curcumin-based interventions and endoscopic approaches for metabolic disorders. His research skills span clinical trials, meta-analyses, translational studies, and consensus guideline development. Recognized globally, Dr. Musso has authored 101 documents, accrued 12,017 citations, and holds an impressive h-index of 49 (Sept 2025). His honors include co-authoring international consensus statements and leading global research collaborations. With his proven excellence in research, teaching, and clinical innovation, Dr. Musso continues to advance the field of hepatology and metabolic medicine while shaping future directions in precision healthcare.

Profile: Scopus | ORCID

Featured Publications

  • Musso, G., Mariano, F., Mella, A., Pinach, S., & Gambino, R. (2025, August 7). Meal-Induced NF-κB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. MedComm, 6(8), e70122.

  • Carpenito, N., Leporati, M., Sciarrillo, A., Pensa, A., Gambino, R., Musso, G., Mella, A., Biancone, L., Risso, D., Mariano, F., & Cosseddu, D. (2025, May 16). LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter baumannii. Antibiotics (Basel), 14(5), 517.

  • Musso, G., Mella, A., Mariano, F., Cassader, M., De Michieli, F., Riva, A., Petrangolini, G., Togni, S., Pinach, S., & Gambino, R. (2024). Impaired Postprandial GLP-2 Response Enhances Endotoxemia, Systemic Inflammation, and Kidney Injury in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Effect of Phospholipid Curcumin Meriva. Gut Microbes, 16(1), article 2424907.

  • Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., Leone, N., Castellino, F., Cassader, M., & Gambino, R. (2025, February 1). Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Hepatology, 81(2), 560–575.

  • Musso, G., Pinach, S., Saba, F., De Michieli, F., Cassader, M., & Gambino, R. (2024, July). Endoscopic Duodenal Mucosa Ablation Techniques for Diabetes and Nonalcoholic Fatty Liver Disease

 

Xingwang Yao | Health Professions | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Xingwang Yao | Health Professions | Best Researcher Award

The Second Xiangya Hospital (Central South University, China) | China

Dr. Yao Xingwang is a senior nurse and accomplished clinical researcher at the Operating Department, Xiangya Second Hospital, Central South University, China. With a strong background in clinical nursing, patient care, and interdisciplinary medical research, he has established himself as a leading figure in the integration of nursing practice with scientific innovation. His professional journey reflects dedication to enhancing the quality of healthcare services through advanced nursing strategies, patient-centered interventions, and translational research. Dr. Yao has actively contributed to the development of innovative treatment methods, clinical nursing guidelines, and healthcare technologies that improve patient outcomes in complex medical conditions. He has also played a key role in research projects funded by provincial and institutional bodies, focusing on areas such as cancer therapy, cardiovascular health, chronic disease management, and perioperative nursing care. Beyond clinical practice and research, Dr. Yao has contributed to academic literature through peer-reviewed journal articles, patents, and textbooks. His ability to bridge the gap between evidence-based nursing and real-world clinical application makes him a highly respected professional in his field. Dr. Yao’s leadership, innovation, and scholarly contributions position him as a distinguished candidate for recognition in international research awards.

Professional Profile

Education

Dr. Yao Xingwang pursued his academic journey at Central South University, one of China’s leading institutions in nursing education and medical sciences. He obtained a Bachelor of Science in Nursing, which laid the foundation for his clinical expertise and patient-centered approach in healthcare. Building upon this, he completed his Master of Science in Nursing under the supervision of esteemed faculty, where he deepened his understanding of advanced nursing practices, clinical interventions, and evidence-based care models. Throughout his education, Dr. Yao developed strong research skills, participating in academic projects that explored the intersections of nursing care and biomedical sciences. His postgraduate studies enabled him to contribute to multidisciplinary research teams, enriching his clinical knowledge with a solid research background. His academic foundation not only provided him with technical expertise but also instilled in him the values of professionalism, compassion, and scientific inquiry. This balance of clinical knowledge and academic training shaped him into a professional capable of leading complex nursing projects and conducting impactful clinical studies. His educational background has been the cornerstone of his career success, empowering him to blend theoretical knowledge with practical applications in the advancement of nursing science and patient care.

Professional Experience

Dr. Yao Xingwang has built an extensive professional career at the Operating Department, Xiangya Second Hospital, Central South University, where he has served in various capacities with increasing responsibility. His early experience as a clinical nurse provided him with hands-on expertise in perioperative care, surgical assistance, patient monitoring, and emergency response. Through dedication and continuous professional development, he advanced to the role of senior nurse, where he has been responsible for supervising clinical teams, ensuring adherence to nursing protocols, and implementing high standards of patient safety and care quality. In addition to his clinical responsibilities, Dr. Yao has been deeply engaged in medical research projects, serving as both a principal investigator and key member in studies supported by provincial foundations and health commissions. His professional experience extends to academic contributions, including publishing in high-impact journals and contributing to textbooks on nursing management and clinical practices. He has also been active in developing innovative healthcare devices, holding patents that address practical clinical challenges. Dr. Yao’s career reflects a seamless integration of nursing service, research innovation, and leadership, making him a role model for aspiring nursing professionals and a respected figure in the field of healthcare.

Research Interest

Dr. Yao Xingwang’s research interests lie at the intersection of nursing science, medical innovation, and patient-centered care. His work focuses on clinical nursing quality evaluation, mindfulness-based interventions for patients with chronic conditions, and the development of evidence-based nursing protocols to improve treatment outcomes. He has contributed significantly to research in cancer therapy, investigating the role of autophagy in cancer stem cell treatment and advancing photodynamic therapy strategies. In cardiovascular nursing, his studies have explored the mechanisms of myocardial injury and interventions that can reduce patient mortality and morbidity. Additionally, Dr. Yao has shown keen interest in mental health within nursing practice, leading projects that examine the impact of mindfulness therapy on depression, anxiety, and cognitive function in elderly diabetic patients. His research also extends to the development of clinical tools and devices, with patents addressing surgical and postoperative care needs. A common theme across his research is the integration of advanced biomedical insights with nursing interventions, ensuring that scientific advancements translate into tangible improvements in patient care. Dr. Yao’s research interests not only address pressing healthcare challenges but also reflect a vision of holistic, evidence-based nursing practice with global impact.

Research Skills

Dr. Yao Xingwang possesses a comprehensive set of research skills that complement his clinical expertise and enable him to conduct high-impact studies in nursing and healthcare. He is proficient in clinical trial design, data collection, and statistical analysis, allowing him to evaluate the effectiveness of nursing interventions with precision. His skills in laboratory techniques support his involvement in biomedical research projects, particularly in cancer biology and cardiovascular studies. Dr. Yao is experienced in the use of advanced imaging tools, including magnetic resonance imaging, for clinical research purposes. He is also skilled in qualitative and quantitative research methodologies, enabling him to address both patient experiences and measurable clinical outcomes. Beyond technical skills, Dr. Yao demonstrates strong project management capabilities, having successfully coordinated multidisciplinary research teams and contributed to projects funded by major provincial and institutional bodies. His ability to translate research findings into practical nursing protocols showcases his applied research strength. Furthermore, his editorial and textbook contributions reflect his academic writing and scientific communication skills. Collectively, these skills underscore his capacity to bridge clinical practice with rigorous research, positioning him as a versatile researcher dedicated to improving patient outcomes through evidence-based nursing innovations.

Awards and Honors

Dr. Yao Xingwang has earned recognition through his contributions to nursing research, clinical practice, and innovation. His scholarly achievements include publications in esteemed journals such as the International Journal of Molecular Medicine, FASEB Journal, and Medicine (Baltimore), where his work has advanced understanding in areas of degenerative disease, cancer biology, and clinical interventions. His role as co-first author and corresponding author in several papers highlights his leadership and intellectual contributions to collaborative research. Dr. Yao has also been honored for his innovation in healthcare technologies, holding utility model patents for devices such as adjustable pancreatic juice diversion systems, multifunctional operating bed covers, and specialized drainage devices for cardiac surgery. These patents demonstrate his ability to identify clinical challenges and provide practical, patient-focused solutions. Additionally, his editorial contributions as compiler and deputy editor of nursing and clinical surgery textbooks reflect recognition of his academic expertise and teaching value. These honors underscore his influence in shaping nursing knowledge, advancing clinical practice, and fostering healthcare innovation. Collectively, Dr. Yao’s awards and honors showcase a career defined by excellence, leadership, and impactful contributions to both academic research and clinical nursing practice.

Publication Top Notes

  • FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro — 2023 — 2 citations

Conclusion

In conclusion, Dr. Yao Xingwang exemplifies the qualities of a distinguished nurse researcher, clinician, and innovator. His career has been marked by an exceptional combination of hands-on nursing excellence, groundbreaking research contributions, and dedication to improving healthcare outcomes. By bridging clinical nursing with advanced biomedical research, he has advanced patient care in oncology, cardiovascular health, chronic disease management, and mental health interventions. His patents and publications stand as evidence of his innovative spirit and scholarly productivity, while his editorial work reflects a commitment to knowledge dissemination and professional education. Dr. Yao’s leadership in clinical projects, combined with his patient-centered approach, highlights his ability to influence both practice and policy within nursing science. With a proven track record of success and a clear vision for future contributions, he is well-positioned to expand his global collaborations, publish in leading international journals, and assume greater leadership roles in the academic and healthcare communities. Dr. Yao’s achievements and potential make him not only deserving of recognition but also an inspiring role model for the next generation of nursing professionals committed to advancing science and society.

Mirjana Cvetkovic | Health Professions | Best Researcher Award

Published on by WSA Awards

Dr. Mirjana Cvetkovic | Health Professions | Best Researcher Award

Consultant CICI and MCS from Great Ormond Street Hospital | United Kingdom

Dr. Mirjana Cvetkovic is an internationally recognised Consultant in Paediatric Cardiac Anaesthesia and Intensive Care at Great Ormond Street Hospital (GOSH), United Kingdom. With over two decades of clinical and academic experience, she has made significant contributions to paediatric critical care, medical simulation, and global health. She has a strong background in ECMO management, perioperative care for children with complex congenital heart diseases, and multidisciplinary education. Her leadership roles include Educational Lead at the Cardiac Intensive Care Unit (CICU) at GOSH, Honorary Lecturer at University College London, and member of the EuroELSO Scientific Committee. Dr. Cvetkovic has pioneered innovative simulation-based training, web-based educational platforms, and advanced perioperative clinical pathways, notably the MIRACCLE initiative. She is deeply committed to humanitarian medical work, having led capacity-building projects for paediatric cardiac care in low-resource settings across Africa and Asia. Her research integrates virtual reality, advanced simulation, and multidisciplinary cardiothoracic education. A prolific educator and active member of numerous professional societies, she continues to shape the next generation of paediatric cardiac specialists. Her career is marked by a commitment to improving patient outcomes, fostering international collaboration, and advancing the science and practice of paediatric cardiac intensive care.

Professional Profile

Scopus Profile | ORCID Profile

Education

Dr. Cvetkovic earned her Medical Doctor degree from the University of Copenhagen, Denmark, followed by specialty education in Anaesthesia and Intensive Care accredited by Styrelsen for Patientsikkerhed, Copenhagen. She achieved her MRCP in Anaesthesia from the Royal College of Anaesthetists, UK completed equivalence to GRID training in Paediatric Intensive Care at GOSH. She further specialised under the Scandinavian Society of Anaesthesiology and Intensive Care (SSAI), undertaking subspecialty training in paediatric and adult anaesthesia and intensive care across Denmark, Sweden, Norway, Finland, and Iceland. She completed a prestigious fellowship in ECMO and Paediatric Cardiac Intensive Care at GOSH. Her academic journey also includes advanced simulation instructor certifications from the University of Copenhagen (CAMES) and Harvard University, Boston. This rigorous and diverse training framework has equipped her with cutting-edge skills in paediatric cardiac anaesthesia, intensive care, simulation-based education, and global health programme design, enabling her to lead transformative initiatives in clinical and educational domains worldwide.

Professional Experience

Dr. Cvetkovic’s career spans multiple leadership and clinical roles in leading healthcare institutions. She has served as Consultant Paediatric Cardiac Anaesthetist and Intensivist at GOSH, where she provides perioperative care and intensive management for children undergoing complex cardiac surgery. She is also an Honorary Lecturer at University College London, actively contributing to the Institute for Cardiovascular Science. Her earlier appointments include Consultant roles at University Hospitals of Leicester, UK, and Locum Consultant in Paediatric Cardiac Anaesthesia at the Royal Hospital for Children, Glasgow. She has held senior fellowships in paediatric intensive care, neonatal care, and ECMO at GOSH and previously worked extensively in Denmark as a Junior Consultant, Specialty Registrar, and Anaesthetist. Dr. Cvetkovic has developed and led major simulation training programmes for multidisciplinary teams, spearheaded international ECMO education at EuroELSO and ESPNIC conferences, and created fast-track surgical recovery pathways. Her global impact extends to humanitarian missions, where she has strengthened paediatric cardiac services in developing countries through structured training, simplified protocols, and team-based education, making her a recognised leader in both clinical excellence and global health advancement.

Research Interests

Dr. Cvetkovic’s research interests focus on paediatric cardiac anaesthesia, intensive care protocols, and extracorporeal life support (ECMO), with a strong emphasis on simulation-based training and education. She is particularly engaged in developing and integrating virtual reality and 3D printing technologies into clinical training for cardiothoracic teams. Her work also explores fast-track recovery pathways for paediatric cardiac surgery, advanced perioperative pain management strategies, and multidisciplinary protocols to enhance patient safety and outcomes. International collaboration is central to her research, as reflected in her MIRACCLE platform, which facilitates knowledge-sharing among global paediatric cardiology and intensive care communities. She contributes to projects aimed at optimising resuscitation courses, improving inter-hospital transport safety, and developing advanced educational models for ECMO and critical care emergencies. Through partnerships with organisations like EuroELSO and ESPNIC, Dr. Cvetkovic is advancing research that bridges cutting-edge medical technology with hands-on clinical application, ensuring that innovations are not only scientifically sound but also feasible for real-world implementation, including in low-resource healthcare systems.

Research Skills

Dr. Cvetkovic possesses a wide range of research and educational skills, integrating clinical expertise with advanced training methodologies. She is proficient in simulation-based research, designing and leading large-scale multidisciplinary training programmes for paediatric cardiac and intensive care teams. Her skills include curriculum development, virtual and augmented reality integration, and educational platform creation (e.g., MIRACCLE). She is experienced in ECMO education, paediatric transoesophageal echocardiography (TOE) training, and developing specialised protocols for perioperative care and cardiac ICU management. She has contributed to international conference workshops, peer-reviewed publications, and collaborative research studies in Scopus and other indexed journals. Her humanitarian project skills include capacity-building strategies, protocol standardisation, and team-training in low-resource settings. She is adept at using structured educational tools like the WHO Surgical Safety Checklist, SAFE communication, and SCAMPs. Dr. Cvetkovic’s ability to combine clinical precision with innovative teaching techniques makes her a highly effective research leader and educator, capable of translating complex clinical concepts into practical, scalable solutions.

Awards and Honours

Dr. Cvetkovic has earned recognition for her exceptional contributions to paediatric cardiac anaesthesia, intensive care, and medical simulation on both national and international platforms. As a EuroELSO Scientific Committee Member, she has influenced the global ECMO education agenda and been invited to lead major simulation-based workshops at EuroELSO, ESPNIC, and EAPS conferences. She has received formal commendations for her humanitarian work in Africa and Asia, where her leadership in establishing sustainable paediatric cardiac units has had lasting health impacts. Her role as an Honorary Lecturer at University College London acknowledges her academic influence, while invitations to deliver lectures and training across Europe, the Middle East, Asia, and Africa demonstrate her global standing. Certification as an Advanced Medical Simulation Instructor by Harvard University and the University of Copenhagen further underscores her excellence in clinical education. She is an active member of leading professional societies including ESPA, SPA, EACTA, SCA, AMEE, IPSS, ESPNIC, DASAIM, and PICS, reflecting her respected status in the field. Her career achievements reflect not only her clinical expertise but also her dedication to global health education and research innovation.

Publication Top Notes

  • “Bridging Europe” advancing Education: The 12th Educational Corner at EuroELSO 2024 conference in Krakow, Poland — 2025

  • “Bridging the Gap” international ECLS training and simulation – evaluation of the 10th educational corner on EuroELSO congress 2022 in London, United Kingdom — 2023

  • Clinical Guidelines for Routine Neuromonitoring in Neonatal and Pediatric Patients Supported on Extracorporeal Membrane Oxygenation — 2023

  • Long-Term Quality of Life in Congenital Heart Disease Surgical Survivors: Multicenter Retrospective Study of Surgical and ICU Explanatory Factors — 2023

  • Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension in a 5-year-old Girl with No Risk Factors — 2022

  • Results of EuroELSO Neurological Monitoring and Neurodevelopmental Outcome Survey — 2021

  • Challenges in Paediatric Cardiac Anaesthesia in Developing Countries — 2018

  • Comparison of Early Outcomes for Normothermic and Hypothermic Cardiopulmonary Bypass in Children Undergoing Congenital Heart Surgery — 2018

  • Brain monitoring in adult and paediatric ECMO patients: the importance of early and late assessments — 2017

  • Real-life use of vasopressors and inotropes in cardiogenic shock-observation is necessarily ‘theory-laden’ — 2016

Conclusion

Dr. Mirjana Cvetkovic is a distinguished clinician, educator, and researcher whose work has transformed paediatric cardiac anaesthesia and intensive care practices worldwide. At Great Ormond Street Hospital, she combines high-level clinical expertise with pioneering educational initiatives that have set new benchmarks in simulation-based medical training. Her MIRACCLE platform and advanced multidisciplinary programmes have significantly improved knowledge exchange in cardiothoracic care. Beyond her institutional role, her humanitarian missions have established sustainable paediatric cardiac services in resource-limited settings, directly impacting countless young lives. Her research seamlessly integrates innovative technologies such as virtual reality and 3D printing with real-world clinical application, contributing to safer, more efficient care pathways. Actively engaged in global collaborations, she influences medical education and practice at an international scale. With her combination of technical skill, academic leadership, and humanitarian dedication, Dr. Cvetkovic exemplifies the qualities of a world-class medical professional and is exceptionally deserving of recognition for her contributions to health professions research and service.

Farid Badria | Health Professions | Best Researcher Award

Published on by WSA Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Published on by WSA Awards

Dr. Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Researcher from Research Center Hargeisa Group Hospital, Somalia

Dr. Sakarie Mustafe Hidig is a dedicated clinical researcher and experienced surgeon with extensive international medical training and practice. Having served in various surgical departments across China and Somalia, he has developed strong expertise in hepatobiliary, gastrointestinal, trauma, and minimally invasive surgeries. Fluent in Somali, English, Chinese, Arabic, and French, Dr. Hidig’s multilingual capabilities have supported his ability to work across cultural and institutional boundaries. He is also a published author in numerous peer-reviewed journals, covering topics such as gastrointestinal bleeding, colorectal cancer surgery, trauma-related interventions, and case reports in orthopedic and abdominal surgery. His academic background, combined with practical knowledge and research insight, enables him to contribute effectively to both clinical operations and scientific advancement. With editorial board roles and peer review certifications, he is actively involved in shaping contemporary medical literature. As a member of multiple medical associations, including the Somali Medical Association, African Medical Association, and China Medical Association, Dr. Hidig continues to impact the regional and global medical communities. His commitment to patient care, clinical research, and academic excellence highlights his suitability for prestigious recognitions such as the Best Researcher Award.

Professional Profile

Education

Dr. Sakarie Mustafe Hidig possesses a strong academic foundation in the field of medicine and surgery, with a clear focus on clinical specialization and language proficiency. He earned his Doctor of Surgery from Zhejiang University, School of Medicine, where he gained advanced knowledge in surgical techniques and clinical research methodologies. Prior to this, he obtained his Master of Surgery from Xinjiang Medical University, where he deepened his understanding of general surgery and patient care. His medical journey began with a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Youjiang Medical University for Nationalities, equipping him with comprehensive skills in diagnosing and managing complex medical cases. Complementing his medical training, Dr. Hidig also holds a Diploma from Guangxi University for Nationalities, School of Languages, which reflects his commitment to cultural competence and communication, vital for working in multicultural medical settings. This well-rounded educational pathway reflects both academic excellence and an adaptive mindset, allowing him to function effectively in diverse clinical and research environments. His formal qualifications from esteemed Chinese institutions have positioned him to serve in demanding healthcare systems and contribute significantly to the fields of clinical surgery and medical science.

Professional Experience

Dr. Sakarie Mustafe Hidig has amassed a wealth of professional experience in both clinical and academic settings, working with prestigious hospitals and institutions across Asia and Africa. He has served in the Division of Hepatobiliary and Pancreatic Surgery at the Fourth Affiliated Hospital, School of Medicine, Zhejiang University, where he engaged in complex surgical procedures and clinical research. He also contributed his expertise at the Affiliated Hospital of Youjiang Medical University for Nationalities and the Emergency & Trauma Surgery Department of the First Affiliated Hospital of Xinjiang Medical University, enhancing his capabilities in emergency interventions and trauma management. Additionally, he has worked in the Gastrointestinal Surgery Department of the Affiliated Hospital of Xuzhou Medical University, as well as various roles at Hargeisa Group Hospital and Hargeisa International Hospital, where he handled general and emergency surgeries. His hands-on experience across multiple departments underscores his adaptability and comprehensive surgical proficiency. Throughout his career, Dr. Hidig has consistently demonstrated a commitment to clinical excellence, patient care, and professional development. His experience spans public and private healthcare sectors, reflecting his ability to meet high clinical standards in diverse medical systems.

Research Interests

Dr. Sakarie Mustafe Hidig’s research interests are deeply rooted in clinical surgery, trauma medicine, and gastrointestinal disorders. He has explored a wide range of topics, from emergency surgery for severe chest trauma to the application of cutting-edge procedures in minimally invasive colorectal surgeries. His research often centers on improving surgical outcomes, reducing post-operative complications, and applying innovative diagnostic tools in clinical settings. He has shown a strong interest in analyzing rare and complex medical cases, such as small bowel bleeding associated with hematologic malignancies or arterial gastrointestinal fistulas, which reflect his dedication to solving challenging clinical problems. Furthermore, he is interested in comparative pharmacological studies, such as those involving amiodarone and propafenone in arrhythmia treatment, indicating his interdisciplinary approach to research. His work in knee arthroplasty and bone tumor management shows his commitment to improving orthopedic surgical care. Overall, Dr. Hidig’s research aims to bridge clinical practice with scientific inquiry, enabling evidence-based improvements in surgical procedures and patient outcomes. His interests continue to expand as he contributes to both routine and specialized areas of medical research, with a vision for developing patient-centered, efficient, and innovative surgical interventions.

Research Skills

Dr. Hidig possesses a robust set of research skills that complement his clinical expertise. He is proficient in conducting literature reviews, designing and implementing clinical research protocols, analyzing medical data, and publishing in peer-reviewed journals. A notable strength is his capability in SPSS data analysis, which he applies in interpreting surgical outcomes and clinical trials. His experience as a peer reviewer and editorial board member has refined his understanding of research quality and scholarly communication. He also excels in case study documentation, having authored several rare case reports that have been published internationally. His skills extend to laparoscopic and minimally invasive surgical techniques, where he has not only practiced but also contributed to methodological advancements through his research. Additionally, he demonstrates competence in Microsoft Office tools, crucial for creating presentations, reports, and manuscripts. With an interdisciplinary approach, he often integrates clinical observations with evidence-based research to produce impactful findings. His multilingual ability aids in cross-border collaborations and academic exchanges. Altogether, Dr. Hidig’s research skills empower him to lead clinical studies, contribute to scholarly discourse, and innovate within the surgical field.

Awards and Honors

Dr. Sakarie Mustafe Hidig has been recognized by multiple esteemed medical and research organizations for his academic and professional contributions. He holds the distinction of being a Young Research Fellow Member of the Somali Association for Science (SAS), reflecting his early recognition as an emerging leader in clinical research. His membership ID SAS/SYRFM/088/2023 signifies his formal acknowledgment within this scholarly body. Additionally, he is a Regular Fellow Member of the International Organization for Academic and Scientific Development (IOASD), which attests to his ongoing engagement in global scientific communities. Dr. Hidig is also a respected member of the Somali Medical Association, the African Medical Association, and the China Medical Association, organizations that honor excellence in healthcare practice and research. Through these affiliations, he has participated in various conferences, professional trainings, and collaborative research initiatives. His editorial board memberships and certifications as a peer reviewer further underscore the trust placed in him by academic journals and the broader research community. These accolades and roles demonstrate his dedication to advancing the frontiers of medical science and his continued influence on international platforms of surgical and clinical research.

Conclusion

In summary, Dr. Sakarie Mustafe Hidig exemplifies the ideal candidate for recognition through the Best Researcher Award. With a solid academic foundation, diverse clinical experience, and an impressive portfolio of research contributions, he brings a multifaceted approach to modern surgical science. His career reflects a continuous commitment to improving patient outcomes, advancing surgical techniques, and promoting scholarly excellence. Fluent in five languages and skilled in both qualitative and quantitative research methods, he seamlessly integrates global perspectives into his practice and publications. Dr. Hidig’s work spans complex case reports, pharmacological studies, trauma and gastrointestinal surgery, and orthopedic procedures, demonstrating a wide scope of knowledge and versatility. His active participation in academic communities, professional societies, and editorial review boards further enhances his reputation as a leader in the field. As he continues to make meaningful contributions to healthcare and clinical research, his achievements serve as a benchmark for aspiring medical professionals. Recognizing his efforts through this award would not only honor his past accomplishments but also encourage continued innovation and collaboration in the global medical community.

Publications Top Notes

  1. Exploring the Role of m7G Modification in Cancer: Mechanisms, Regulatory Proteins, and Biomarker Potential
    Authors: Y Zhang, W Xu, C Peng, S Ren, SM Hidig, C Zhang
    Journal: Cellular Signalling, 2024, Article ID: 111288
    Citations: 10

  2. Understanding the Incidence, Screening, and Burden of Cancer in Somalia: A Literature
    Authors: SM Hidig, MM Adan
    Journal: GSJ, Vol. 12 (1), 2024
    Citations: 3

  3. An Overview of Current Pancreatic Cancer Diagnosis and Treatment in China
    Author: SM Hidig
    Journal: IOASD Journal of Medical and Pharmaceutical Sciences, Vol. 1 (1), pp. 60–67, 2024
    Citations: 2

  4. High Hepatocellular Carcinoma Rates in African Nations: Challenges and Possibilities
    Author: SM Hidig
    Journal: International Journal of Recent Research in Interdisciplinary Sciences, 2024
    Citations: 2

  5. Does Mild Flexion of the Femoral Prosthesis in Total Knee Arthroplasty Result in Better Early Postoperative Outcomes?
    Authors: H Zhou, ZR Wu, XY Chen, LS Zhang, JC Zhang, SM Hidig, S Feng, et al.
    Journal: BMC Musculoskeletal Disorders, Vol. 24 (1), Article 711, 2023
    Citations: 6

  6. Diagnostic Value of Mean Platelet Volume Combined with Thromboelastography for Coagulation State after Total Knee Arthroplasty
    Authors: JH Chen, H Zhou, Q Zhang, H Wang, SM Hidig, XY Chen, S Feng
    Journal: Clinical Hemorheology and Microcirculation, Vol. 84 (3), pp. 321–331, 2023
    Citations: 4

  7. The Challenges Facing the Healthcare System in Somalia: A Review and The Way Forward
    Authors: SM Hidig, MHA Rahman Ali, GA Egeh
    Journal: Healthcare Issues, Vol. 3 (1), pp. 6–16, 2024
    Citations: 2

  8. Assessing Healthcare Challenges in Somalia: A 2024 Perspective
    Author: SM Hidig
    Journal: ACH Medical Journal, Vol. 3 (1), pp. 346–347, 2024
    Citations: 2

  9. Traditional Education and Modern Teaching in Somaliland: A Comprehensive Review
    Authors: SM Hidig, AM Saed
    Journal: Journal of Arts Humanities and Social Sciences (GASJAHSS), 2023
    Citations: 2

  10. Promotion Policy and Employee Performance in Golls Telecommunication Company in Dhahar District, Puntland, Somalia
    Author: AM Hidig
    Institution: Kampala International University, 2014
    Citations: 2

 

 

Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34

Yana Zhang | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Yana Zhang | Medicine and Dentistry | Best Researcher Award

Associate Professor from Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Dr. Yana Zhang is an accomplished academic and researcher in the field of Otorhinolaryngology–Head and Neck Surgery, currently serving as an Associate Professor at the Third Affiliated Hospital of Sun Yat-sen University. She holds a Ph.D. from Tongji Medical College, Huazhong University of Science and Technology, China, and has completed a postdoctoral fellowship at Northwestern University, USA. With over a decade of research and clinical experience, Dr. Zhang has established herself as a leading figure in allergy and airway inflammation research. Since joining Sun Yat-sen University through the prestigious “Hundred Talents Program” in 2020, she has been spearheading multiple high-impact research projects. She has published more than 40 peer-reviewed articles in journals such as Nature Immunology, J Allergy Clin Immunol, J Exp Med, and Am J Respir Crit Care Med, many as first or corresponding author. Her research focuses on the molecular mechanisms underlying allergic inflammation and chronic rhinosinusitis. Dr. Zhang plays influential roles in several national academic and medical committees and is a regular reviewer for high-impact journals and research foundations. Her work is recognized for its translational value, aiming to improve treatment outcomes for patients with allergic diseases and ENT disorders.

Professional Profile

Education

Dr. Yana Zhang pursued her higher education in medicine and specialized in Otorhinolaryngology–Head and Neck Surgery. She earned her Ph.D. from Tongji Medical College at Huazhong University of Science and Technology in 2014, one of China’s most respected institutions in medical research. Her doctoral work focused on immunological mechanisms and inflammatory processes in chronic rhinosinusitis and other airway-related disorders, laying the groundwork for her later research. She subsequently enhanced her academic portfolio by undertaking postdoctoral training at Northwestern University in the United States from 2016 to 2020. This international experience enabled her to refine her research methods and establish collaborations with world-renowned immunologists and clinical scientists. Her training at Northwestern offered her exposure to advanced biomedical research techniques and allowed her to integrate global best practices into her work. This comprehensive academic background has provided her with a solid foundation to pursue advanced research in translational medicine, particularly in immune-mediated diseases of the upper respiratory tract. Her education reflects a blend of rigorous Chinese medical training and cutting-edge international research exposure, positioning her as a global scholar with a deep understanding of both clinical and experimental approaches.

Professional Experience

Dr. Zhang began her professional academic career after completing her Ph.D. in 2014. Following this, she undertook a postdoctoral fellowship at Northwestern University in the United States from 2016 to 2020, where she worked on translational research projects focused on immunoregulation and inflammatory diseases. This experience significantly expanded her research expertise and network. In 2020, she returned to China to join the Third Affiliated Hospital of Sun Yat-sen University as an Associate Professor through the university’s highly competitive “Hundred Talents Program.” In this role, she leads a dynamic research team working on inflammatory mechanisms in chronic rhinosinusitis and allergy-related comorbidities. Dr. Zhang also holds several influential academic appointments, including expert reviewer roles for the Ministry of Education and the National Natural Science Foundation of China. She serves on various national committees under the Chinese Medical Association and other professional bodies, contributing to policy, research direction, and academic evaluations. She also plays a key role in mentoring graduate students and guiding young researchers. Her multidisciplinary experience bridges clinical practice and molecular science, allowing her to translate laboratory findings into potential therapies for ENT and allergic conditions.

Research Interests

Dr. Yana Zhang’s research centers on immunological mechanisms and therapeutic strategies targeting eosinophilic inflammation and allergic airway diseases. Her work addresses chronic rhinosinusitis with nasal polyps (CRSwNP), a debilitating and recurring inflammatory disorder, and aims to unravel the molecular underpinnings of steroid resistance and epithelial barrier dysfunction. She has explored novel pathways involving fatty acids, IL-17A, vitamin D, and extracellular vesicles in allergic disease models. Her recent studies investigate the roles of epithelium-derived chemokines, Charcot-Leyden crystals, and immune checkpoints in modulating inflammation and tissue remodeling. Another central focus of her research is the interaction between environmental factors, such as air pollution, and the immunopathology of rhinitis and asthma. Dr. Zhang’s goal is to translate her laboratory findings into effective therapeutic strategies that can be applied in clinical settings. Her research also spans the field of immune metabolism, including succinate signaling and its effect on regulatory T cells, with implications for systemic autoimmune and allergic diseases. Her interdisciplinary work combines molecular biology, clinical otorhinolaryngology, and immunotherapy to address urgent healthcare challenges in allergy and airway inflammation.

Research Skills

Dr. Zhang is equipped with a comprehensive skill set in both clinical and molecular research. Her expertise includes cellular immunology, molecular biology, transcriptomics, histopathology, and translational medicine. She is proficient in designing and conducting in vivo and in vitro models of airway inflammation, including murine models of eosinophilic rhinosinusitis. She has extensive experience in flow cytometry, ELISA, immunohistochemistry, RNA sequencing, confocal microscopy, and CRISPR-Cas9 gene editing technologies. Her postdoctoral training at Northwestern University further enhanced her proficiency in advanced immunological assays, including Treg stability assays, metabolite analysis, and cell differentiation studies. Dr. Zhang is skilled in developing predictive models and statistical algorithms to interpret clinical outcomes and endotypes in allergic patients. Additionally, she collaborates with bioinformatics experts to analyze large datasets, facilitating biomarker discovery and patient stratification. Her capacity to bridge bench-side experimentation with clinical relevance makes her a leader in translational allergy research. Dr. Zhang’s multidisciplinary research environment allows her to apply both clinical acumen and lab-based expertise to uncover new therapeutic avenues in chronic inflammatory diseases.

Awards and Honors

Dr. Yana Zhang has received multiple accolades that reflect her scholarly excellence and leadership in biomedical research. Most notably, she was selected as a Young Top Talent under the Guangdong “Pearl River Talent Program” in 2022, a prestigious recognition for emerging scientific leaders in China. In 2020, she was recruited through the “Hundred Talents Program” at Sun Yat-sen University, a national initiative to attract top researchers to Chinese academic institutions. These honors underscore her scientific impact and potential to contribute to national innovation goals. In addition to these major recognitions, Dr. Zhang has been invited to serve as a grant reviewer for the National Natural Science Foundation of China, a testament to her credibility and leadership in the scientific community. She is also an expert evaluator for doctoral dissertations under the Ministry of Education. Her editorial and peer-review responsibilities for internationally reputed journals further reflect her standing in the academic field. Collectively, these awards and responsibilities highlight her commitment to advancing research, mentoring junior scientists, and shaping the future of otorhinolaryngology and immunology in China and beyond.

Conclusion

Dr. Yana Zhang stands out as an exceptional researcher and academic whose work has had a profound impact on the field of immunology and otorhinolaryngology. Her career reflects a harmonious blend of rigorous academic training, international experience, and a deep commitment to translational medicine. Through cutting-edge research on eosinophilic inflammation and allergic diseases, she has significantly advanced our understanding of the pathophysiological mechanisms underlying chronic airway disorders. Her contributions are well-documented through a robust portfolio of publications in top-tier scientific journals and her leadership in multiple national research projects. Furthermore, her active involvement in academic societies and committees showcases her dedication to the scientific community. Dr. Zhang’s efforts not only enhance clinical outcomes for patients but also influence national policy and research directions. Her vision of integrating basic research with clinical application makes her a key figure in developing personalized treatments for allergy and ENT disorders. With continued support and collaboration, Dr. Zhang is poised to make even greater strides in medical science and to serve as a role model for future researchers in China and globally.

Publications Top Notes

  1. Vitamin D impedes eosinophil chemotaxis via inhibiting glycolysis‑induced CCL26 expression in eosinophilic chronic rhinosinusitis with nasal polyps

  • Year: 2025

  • Authors: Weiqiang Huang, Yana Zhang, Yue Li, Junming Ma, Xia Li, Yanjie Jiang, Jianqi Wang, Haotian Wu, Xiaohong Chen, Zizhen Huang, Xifu Wu, Xiaoping Lai, Donglin Li, Lihong Chang, Gehua Zhang

2. Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch

  • Year: 2025

  • Authors: Hai Wang, Danqing Hu, Yang Cheng, Qiong Gao, Kun Liu, Nikita L. Mani, Amy Y. Tang, Radhika Iyer, Beixue Gao, Leyu Sun, Qi Zhou, Qin Yu, Samuel E. Weinberg, Xiaoyu Zhang, Yingzi Cong, Parambir S. Dulai, Yana Zhang, Zheng Liu, Deyu Fang

 

 

Yulin Mo | Pharmaceutical Science | Best Researcher Award

Published on by WSA Awards

Dr. Yulin Mo | Pharmaceutical Science | Best Researcher Award

Shanghai University, China

Mo Yulin is an accomplished researcher and medical professional specializing in pharmacology and traditional Chinese medicine. Born in 1986 in Hezhou, Guangxi, China, he currently serves as a physician at Nanning Hospital of Traditional Chinese Medicine. With over a decade of clinical and research experience, Mo combines medical practice with scientific inquiry, focusing on the mechanistic basis of bone diseases such as glucocorticoid-induced osteoporosis (GIO). He obtained his Master of Medical Science degree in Pharmacology from Guangdong Medical University, where he cultivated a strong foundation in experimental pharmacology, molecular techniques, and data analysis. His academic journey began at Youjiang Medical University for Nationalities, where he earned his Bachelor’s degree in Clinical Medicine. Mo Yulin has actively contributed to several nationally funded research projects and has co-authored high-impact journal articles. His work focuses on the intersection of Traditional Chinese Medicine and modern pharmacological research, particularly targeting bone-related diseases. With a sound understanding of laboratory protocols, animal models, and statistical software, he continues to contribute to both clinical and academic advancements. Mo’s research is well-recognized in peer-reviewed journals and by national scientific foundations, reinforcing his potential as a leading figure in integrative medical research.

Professional Profile

Education

Mo Yulin’s educational background is rooted in a solid blend of clinical and pharmacological sciences. He began his academic journey at Zhaoping County Middle School, completing his secondary education in 2004. He then enrolled at Youjiang Medical University for Nationalities in September 2005, where he pursued a Bachelor’s degree in Clinical Medicine and graduated in June 2010. His interest in the theoretical underpinnings of medicine and drug mechanisms led him to pursue postgraduate studies in Pharmacology. In September 2016, he was admitted to Guangdong Medical University, a recognized institution in medical sciences, where he undertook a full-time Master’s program in Medical Science with a concentration in pharmacology. He completed this program in June 2019. His master’s thesis, titled “Exploring the pathogenesis of GIO and the intervention effect of Danshensu based on TXNIP mediated mitochondrial oxidative phosphorylation,” demonstrated a deep integration of molecular biology, pharmacology, and traditional Chinese medicine. His academic record is also supplemented by participation in various specialized training programs and international summer courses, including workshops on stem cell biology and network pharmacology. This extensive and interdisciplinary academic training has equipped him with a broad understanding of clinical medicine, experimental design, and the pharmacological sciences.

Professional Experience

Mo Yulin has built an impressive career that bridges clinical practice and biomedical research. His professional journey began in June 2010 when he joined the Nanning Hospital of Traditional Chinese Medicine as a medium physician in the Internal Medicine and Physical Examination departments. Over six years in this role, he developed a strong clinical foundation and a growing interest in disease mechanisms and pharmacological interventions. After obtaining his Master’s degree, he returned to the same hospital in June 2019, this time focusing on a broader medical department, where he continues to practice medicine. During his tenure, Mo has maintained a dual focus on patient care and experimental research, allowing him to apply his laboratory insights to real-world medical challenges. He has collaborated with senior professionals and contributed to national-level research, while also mentoring younger colleagues in clinical routines and laboratory practices. His unique ability to translate bench-side findings to bedside interventions highlights his effectiveness as both a clinician and a researcher. With over a decade of continuous professional involvement in the medical field, Mo has shown commendable commitment, especially in the integration of traditional Chinese therapies with modern biomedical strategies.

Research Interest

Mo Yulin’s research interests lie primarily at the intersection of traditional Chinese medicine and modern pharmacological science, with a particular emphasis on bone-related disorders and oxidative stress mechanisms. He is especially passionate about understanding and treating glucocorticoid-induced osteoporosis (GIO) using molecular and cellular approaches. His master’s thesis explored the TXNIP-mediated mitochondrial oxidative phosphorylation pathway as a contributor to bone loss, representing a critical nexus of energy metabolism and bone pathology. Mo is also interested in the pharmacological potential of natural Chinese medicine, including monomer compounds and complex formulations, to treat chronic diseases such as osteoporosis, vascular diseases, and diabetes. Another area of interest includes modeling disease conditions in animals—he has mastered several techniques to establish experimental models, including ovariectomized rats and glucocorticoid-induced fracture models. Additionally, Mo is fascinated by the application of bioinformatics and network pharmacology to identify active compounds in traditional medicines and link them to molecular targets. His broader academic pursuit is to modernize traditional therapies by uncovering their mechanisms of action at the cellular and genetic level. By combining ancient medical wisdom with cutting-edge scientific techniques, he aims to contribute to integrative medicine and develop more effective, evidence-based therapeutic strategies.

Research Skills

Mo Yulin possesses a comprehensive skill set spanning molecular biology, pharmacological modeling, histology, and data analytics. He is highly proficient in conducting experiments involving animal models, particularly in the induction of osteoporosis and bone fractures in rodents. His technical skills include the extraction and culturing of bone marrow mesenchymal stem cells, human osteosarcoma cell lines, and various molecular biology assays like Western blotting, RT-qPCR, MTT assays, plasmid transfection, and siRNA interference. He is also skilled in bone histomorphometry, micro-CT analysis, and both decalcified paraffin and non-decalcified plastic embedding techniques. Mo is adept at performing immunohistochemistry and various types of staining for microscopic analysis. In addition to wet-lab skills, he is well-versed in statistical analysis and scientific computing using software such as SPSS, GraphPad Prism, and ImageJ. His ability to combine laboratory expertise with data interpretation and literature synthesis makes him a competent and independent researcher. Furthermore, he is capable of integrating traditional Chinese medicine theory with modern biochemical analysis, allowing for novel insights into drug mechanisms. These versatile research skills equip him to work on multidisciplinary projects in both academic and clinical research settings.

Awards and Honors

Throughout his academic and professional career, Mo Yulin has been recognized for his analytical acumen and research capability. During his undergraduate studies, he participated in the National College Students Mathematical Modeling Competitions, where he won the second prize in 2006 (Guangxi B group) and the third prize in 2007 (Guangxi group A). These early accomplishments reflected his strong foundation in analytical thinking and a keen interest in applying quantitative methods to solve biomedical problems. Later, his master’s thesis was selected for review by the Academic Degrees Committee of Guangdong Province, a sign of academic excellence. In addition, Mo has participated in several prestigious training programs and conferences, such as the Croucher Foundation’s summer course on Stem Cell Biology and Regenerative Medicine at the Chinese University of Hong Kong. He was also selected for training in Network Pharmacology Technology of Traditional Chinese Medicine and participated in the 9th International Academic Conference on Osteoporosis and Bone Mineral Salt Diseases, contributing to his professional growth and global exposure. These accolades, combined with his inclusion as a project participant in national-level funded research, highlight his growing stature as a serious and capable biomedical researcher.

Conclusion

In conclusion, Mo Yulin is a highly capable and dedicated researcher with a unique profile that bridges clinical medicine and pharmacological science, especially within the framework of Traditional Chinese Medicine. His academic achievements, research capabilities, and publication record affirm his suitability for a distinguished research career. He has already contributed valuable insights into the understanding and treatment of bone-related disorders and oxidative stress, demonstrated by peer-reviewed publications in high-impact journals and successful participation in national research projects. Mo’s well-rounded expertise, from cell culture and animal modeling to statistical data analysis and Chinese medicinal compound evaluation, gives him a holistic view of disease pathology and therapeutic mechanisms. Although a Ph.D. degree and more international collaborations could further enhance his research impact, his current contributions and potential for future work are substantial. Mo Yulin is not only a skilled physician but also a thoughtful researcher whose work continues to bridge gaps between traditional knowledge and modern science. Based on his achievements and potential, he stands out as a strong candidate for the Best Researcher Award.

Publications top Notes

  1. TXNIP contributes to bone loss via promoting the mitochondrial oxidative phosphorylation during glucocorticoid-induced osteoporosis
    Authors: Yulin Mo, Wenxiu Lai, Ying Zhong, Zhuoqing Hu, Meigui You, Minqun Du, Pan Wang, Xinyou Wu, Cailing Chen, Huanmin He, Zhimin Gao, Yaping Xu, Dongtao Wang, Liao Cui, Yajun Yang
    Year: 2021
    Journal: Life Sciences 266 (2021): 118938
  2. Tanshinol alleviates microcirculation disturbance and impaired bone formation by attenuating TXNIP signaling in GIO rats
    Authors: Wenxiu Lai, Yulin Mo, Dongtao Wang, Ying Zhong, Lujiao Lu, Jiajia Wang, Liao Cui, Yanzhi Liu, Yajun Yang
    Year: 2021
    Journal: Frontiers in Pharmacology, 12: 722175
  3. The mechanism of TXNIP-mediated oxidative stress in the disease
    Authors: Mo Yulin, Yang Yajun, Cui Liao
    Year: 2018

 

 

Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology